Connect with us

Hi, what are you looking for?

Stock

US FDA revokes authorization for four COVID treatments

Published

(Reuters) – The U.S. Food and Drug Administration said on Monday it had revoked the emergency use authorization for four COVID-19 treatments, including those from Eli Lilly (NYSE:LLY) and Regeneron (NASDAQ:REGN).

(This story has been corrected to say four treatments, not five, in the headline and paragraph 1)

This post appeared first on investing.com

In this article:
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Could Trump undermine the vote again? Harris’s legal team says it’s not worried.

    Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

    October 21, 2024

    Economy

    BoE’s Greene sticks to view that rate cuts should be gradual

    LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

    October 21, 2024

    Editor's Pick

    A GOP operative accused a monastery of voter fraud. Nuns fought back.

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    October 24, 2024

    Latest News

    Warner Bros. Discovery adds 7.2 million Max subscribers, the streamer’s largest single-quarter jump

    Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

    November 9, 2024

    Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 beneficialinvestmentnow.com